AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JUN 13 - (NewsRx.com & NewsRx.net) -- Women with mild-to-moderate pelvic inflammatory disease (PID) - a leading cause of infertility - who are treated as outpatients have recovery and reproductive outcomes similar to those for women treated in hospitals, according to a study funded by the Agency for Healthcare Research and Quality (AHRQ).
"Treating women with PID in an outpatient setting means receiving care won't disrupt their daily lives and those of their families," said Carolyn Clancy, MD, acting director of AHRQ. "This study provides the first evidence of the comparable effectiveness of outpatient treatment."
The PID Evaluation and Clinical Health (PEACH) study was a randomized clinical trial designed to compare the effectiveness of inpatient and outpatient treatment strategies in preserving fertility and preventing PID recurrence, chronic pelvic pain and ectopic pregnancy for women with mild to moderate PID. Women treated as outpatients received a single injection of cefoxitin and an oral dose of probenecid, followed by a 14-day supply of oral doxycycline. Those treated in a hospital were given multiple intravenous doses of cefoxitin plus doxycycline during a minimum inpatient stay of 48 hours. The women's care then was followed for 35 months to document long-term outcomes.
The short-term clinical improvements were similar for women treated in inpatient and outpatient settings. After 35 months of follow-up, pregnancy rates were nearly equal between the groups, as was the amount of time it took to become pregnant. ...
Source: HighBeam Research, Inpatient, outpatient treatment show comparable long-term...